Stockreport

Recro Pharma: FDA Grants Appeal For IV Meloxicam, Adding Value To The Proposed Acute Care Spin-Out [Seeking Alpha]

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com
PDF Recro Pharma: FDA Grants Appeal For IV Meloxicam, Adding Value To The Proposed Acute Care Spin-Out Recro Pharma ( REPH The appeal news is announced only a couple of days [Read more]